Pacific Edge Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Pacific Edge Stock Forecast and Price Target
The average target price for Pacific Edge's stock set by two renowned analysts in recent months is $0.14, representing a potential upside of approximately 75% from its last closing price if met by 2025. This estimation is based on a high estimate of $0.16 and a low estimate of $0.11. Even if you are not interested in PEB stock, you should still be aware of its competitors.
75.00% Upside
Pacific Edge Fair Value Forecast for 2023 - 2025 - 2030
Pacific Edge's Price has grown in the last five years, jumping from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach $0.09 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HOLX Stock Forecast | Hologic | Outperform |
8
|
$77.19 | Buy/Sell | $81.06 | 8.82% |
QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$41.89 | Buy/Sell | $0.00 | 19.36% |
GH Stock Forecast | Guardant Health | Buy |
6
|
$17.34 | Buy/Sell | $43.00 | 156.63% |
NEO Stock Forecast | NeoGenomics | Outperform |
8
|
$14.16 | Buy/Sell | $20.09 | 41.24% |
MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$18.60 | Buy/Sell | $22.08 | 34.41% |
Pacific Edge Revenue Forecast for 2023 - 2025 - 2030
Pacific Edge's Revenue has grown in the last three years, jumping from $4.95M to $21.03M – an increase of 324.85%. In the next year, analysts predict that Revenue will reach $42.70M – an increase of 103.04%. For the next six years, the forecast is for Revenue to grow by 141.57%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VCYT Stock Forecast | Veracyte | Outperform |
11
|
$19.83 | Buy/Sell | $32.17 | 63.89% |
OPK Stock Forecast | OPKO Health | Outperform |
8
|
$1.01 | Buy/Sell | $6.70 | 296.04% |
NSTG Stock Forecast | NanoString Technologies | - |
7
|
$0.30 | Buy/Sell | $5.02 | -100.00% |
Pacific Edge EBITDA Forecast for 2023 - 2025 - 2030
Pacific Edge's EBITDA has increased by 66.37% In the last three years, going from $-18.91M to $-31.46M. The next year, 3 experts forecast that Pacific Edge's EBITDA will decrease by 32.93%, reaching $-21.10M. In 2030, professionals predict that Pacific Edge's EBITDA will decrease by 124.74%, reaching $7.78M.
Pacific Edge EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Pacific Edge's EBIT has grown, increasing from $-19.13M to $-32.06M – a growth of 67.59%. According to the 3 analysts polled, in the next year, Pacific Edge's EBIT will fall by 28.57%, reaching $-22.90M. By 2030, professionals believe that Pacific Edge's EBIT will have decreased by 117.34%, falling to $5.56M.
Pacific Edge EPS Price Prediction Forecast for 2023 - 2025 - 2030
Pacific Edge's EPS has grown in the last five years, jumping from $-0.03 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach $-0.02 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.